Category:Biosimilars

From Wikipedia: A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expires.

More information on FDA-approved biosimilar products is available through the link.

Note: at this time, due to prioritization, we will de-prioritize adding literature directly related to the evaluation of biosimilars (e.g., an RCT that compares the original product to a biosimilar). If this is content that you desire to see on HemOnc.org, please let us know through the contact email.